FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely neratinib (as neratinib maleate) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only nelarabine in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Brentuximab vedotin only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely necitumumab 16 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely necitumumab 16 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Fedratinib (as fedratinib hydrochloride) 100 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Fedratinib (as fedratinib hydrochloride) 100 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only bortezomib in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Oblimersen only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sonidegib (as sonidegib phosphate) 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sonidegib (as sonidegib phosphate) 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely ribociclib (as ribociclib succinate) 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ribociclib (as ribociclib succinate) 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only pertuzumab in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Trametinib (as trametinib dimethyl sulfoxide) 500 microgram oral tablet Count of base of active ingredient False un Inferred relationship Some
    Trametinib (as trametinib dimethyl sulfoxide) 500 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Trametinib (as trametinib dimethyl sulfoxide) 2 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Trametinib (as trametinib dimethyl sulfoxide) 2 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only ofatumumab in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cannabidiol 100 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cannabidiol 100 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Pralatrexate only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pralatrexate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pralatrexate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Nitrous oxide 1 mL/mL gas for inhalation Count of base of active ingredient False un Inferred relationship Some
    Nitrous oxide 1 mL/mL gas for inhalation Has concentration strength denominator value False un Inferred relationship Some 1
    Nitrous oxide 1 mL/mL gas for inhalation Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely carbon dioxide 1 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely carbon dioxide 1 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbon dioxide 1 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 1
    Nitrous oxide 0.5 mL/mL and oxygen 0.5 mL/mL gas for inhalation Has concentration strength denominator value False un Inferred relationship Some 1
    Nitrous oxide 0.5 mL/mL and oxygen 0.5 mL/mL gas for inhalation Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely helium 1 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely helium 1 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely helium 1 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely air 0.95 milliliter/1 milliliter and carbon dioxide 0.05 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely air 0.95 milliliter/1 milliliter and carbon dioxide 0.05 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely carbon dioxide 0.2 milliliter/1 milliliter and oxygen 0.8 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbon dioxide 0.2 milliliter/1 milliliter and oxygen 0.8 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely carbon dioxide 0.1 milliliter/1 milliliter and oxygen 0.9 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbon dioxide 0.1 milliliter/1 milliliter and oxygen 0.9 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely carbon dioxide 0.05 milliliter/1 milliliter and oxygen 0.95 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbon dioxide 0.05 milliliter/1 milliliter and oxygen 0.95 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely helium 0.79 milliliter/1 milliliter and oxygen 0.21 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely helium 0.79 milliliter/1 milliliter and oxygen 0.21 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
    Product containing precisely helium 0.09 milliliter/1 milliliter and nitrogen 0.56 milliliter/1 milliliter and oxygen 0.35 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely helium 0.09 milliliter/1 milliliter and nitrogen 0.56 milliliter/1 milliliter and oxygen 0.35 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely helium 0.09 milliliter/1 milliliter and nitrogen 0.56 milliliter/1 milliliter and oxygen 0.35 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
    Mepolizumab 100 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Mepolizumab 100 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely paracetamol 500 milligram/1 each tablet for conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely paracetamol 500 milligram/1 each tablet for conventional release oral solution (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Metoprolol tartrate 1 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Metoprolol tartrate 1 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Metoprolol tartrate 1 mg/mL solution for injection Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely aprepitant 40 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely aprepitant 40 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only tafasitamab (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing only tafasitamab in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Belantamab mafodotin only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Trastuzumab emtansine only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Trastuzumab emtansine 100 mg powder for solution for infusion vial Count of base of active ingredient False un Inferred relationship Some
    Trastuzumab emtansine 100 mg powder for solution for infusion vial Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely calcium polystyrene sulfonate 999.34 milligram/1 gram powder for conventional release oral and rectal suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely calcium polystyrene sulfonate 999.34 milligram/1 gram powder for conventional release oral and rectal suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing only polystyrene sulfonate in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing only polystyrene sulfonate in rectal dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only risdiplam (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing only risdiplam in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Risdiplam 750 microgram/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Risdiplam 750 microgram/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing only nitrous oxide in conventional release gas for inhalation (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely potassium chloride 75 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely potassium chloride 75 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Oliceridine only product Count of base of active ingredient False un Inferred relationship Some
    Oliceridine only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing only nitric oxide in conventional release gas for inhalation (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely nitric oxide 980 nanogram/1 milliliter conventional release gas for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely nitric oxide 980 nanogram/1 milliliter conventional release gas for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Viltolarsen only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only viltolarsen in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam Count of base of active ingredient False un Inferred relationship Some
    Prednisolone (as prednisolone metasulfobenzoate sodium) 20 mg/actuation rectal foam Has presentation strength denominator value False un Inferred relationship Some 1
    Bilastine 2.5 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Bilastine 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Bilastine 10 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
    Bilastine 10 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Bilastine only product in oromucosal dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely oxybuprocaine hydrochloride 4 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely oxybuprocaine hydrochloride 4 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing only oxybuprocaine in ocular dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Opicapone 50 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Opicapone 50 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely opicapone 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely opicapone 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1

    Start Previous Page 213 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start